Pricing
  1. JP-listed companies
  2. MIZUHO MEDY CO.,LTD.
  3. Financials
  4. Depreciation & amortization

MIZUHO MEDY CO.,LTD. (4595)

Market cap
¥34.5B
P/E ratio
10.7x
Mizuho Medic develops and manufactures diagnostic test kits for hospitals and consumers, specializing in infectious disease testing including COVID-19 and influenza.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndDepreciation & amortization (Million JPY)YoY (%)
Dec 31, 2025266+16.67%
Dec 31, 2024228+16.63%
Dec 31, 2023195+4.77%
Dec 31, 2022187+8.11%
Dec 31, 2021173-10.39%
Dec 31, 2020193+16.06%
Dec 31, 2019166+71.61%
Dec 31, 201897+25.41%
Dec 31, 201777+18.55%
Dec 31, 201665+24.41%
Dec 31, 201552+5.47%
Dec 31, 201450

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat